Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of NM57S/NC08 alone or with human rabies vaccine
ChiCTR2000033182Phase 2Not yet recruiting
- Sponsor
- Yunnan Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2020
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of NM57S + NC08, human rabies vaccine and rabies immune globulin (human) in rabies (6 arms), sponsored by Yunnan Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Tolerance and safety, Pharmacokinetics and 4 more. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
NM57S + NC08human rabies vaccinerabies immune globulin (human)
03
Conditions
rabies
Beyond the preview
Go deeper on ChiCTR2000033182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033182.